Regulation of gene expression during severe caloric restriction: Lack of induction of p85alpha phosphatidylinositol 3-kinase mRNA in skeletal muscle of patients with Type II (non-insulin-dependent) diabetes mellitus

Diabetologia

Volumn 43, Issue 3, 2000, Pages 356-363

  Andreelli, F ^a   Laville, M ^a   Vega, N ^a   Riou, J P ^a   Vidal, H ^a  

^a INSERM   (France)

Author keywords

GLUT 4; Hexokinase II; Insulin receptor; Insulin resistance; Lipoprotein lipase; Phosphatidylinositol 3 kinase; Rad

Indexed keywords

FATTY ACID; GLYCOGEN SYNTHASE; HEXOKINASE; INSULIN RECEPTOR; KETONE; LIPOPROTEIN LIPASE; MESSENGER RNA; PHOSPHATIDYLINOSITOL 3 KINASE;

ADULT; ARTICLE; CALORIC RESTRICTION; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETOGENESIS; ENZYME INDUCTION; FEMALE; GENE EXPRESSION REGULATION; HUMAN; HUMAN TISSUE; INSULIN RESISTANCE; MALE; MUSCLE BIOPSY; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RNA ANALYSIS; SKELETAL MUSCLE;

EID: 0034075898     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001250050054     Document Type: Article

References (38)

1. 1. Kahn RC (1994) Insulin action, diabetogenes, and the cause of Type II diabetes. Diabetes 43: 1066-1084
2. 2. Yki-Järvinen H (1995) Role of insulin resistance in the pathogenesis of NIDDM. Diabetologia 38: 1378-1388
3. 3. Garvey WT, Maianu L, Huecksteadt TP, Birnbaum MJ, Molina JM, Ciaraldi TP (1991) Pretranslational suppression of a glucose transporter protein causes insulin resistance in adipocytes from patients with non-insulin-dependent-diabetes mellitus and obesity. J Clin Invest 87: 1072-1081
4. 4. Sinha MK, Raineri-Maldonado C, Buchanan C et al. (1991) Adipose tissue glucose transporters in NIDDM: decreased levels of muscle/fat isoform. Diabetes 40: 472-477
5. 5. Rondinone CM, Wang LM, Lonnroth P, Wesslau C, Pierce JH, Smith U (1997) Insulin receptor substrate (1RS) 1 is reduced and IRS-2 is the main docking protein for phosphatidylinositol 3-kinase in adipocytes from subjects with non-insulin-dependent diabetes mellitus. Proc Natl Acad Sci USA 94: 4171-4175
6. 6. Reynet C, Kahn CR (1993) Rad: a member of the Ras family overexpressed in muscle of Type II diabetic humans. Science 262: 1441-1444
7. 7. Vestergaard H, Lund S, Larsen FS, Bjerrum OJ, Pedersen O (1993) Glycogen synthase and phosphofructokinase protein and mRNA levels in skeletal muscle from insulin-resistant patients with non-insulin-dependent diabetes mellitus. J Clin Invest 91: 2342-2350
8. 8. Vestergaard H, Bjorbaek C, Hansen T, Larsen FS, Granner DK, Pedersen O (1995) Impaired activity and gene expression of hexokinase II in muscle from non-insulin-dependent diabetes mellitus patients. J Clin Invest 96: 2639-2645
9. 9. Brunetti A, Brunetti L, Foti D, Accili D, Goldfine ID (1997) Human diabetes associated with defects in nuclear regulatory proteins for the insulin receptor gene. J Clin Invest 97: 258-262
10. 10. Yamagata K, Oda N, Kaisaki PJ et al. (1996) Mutations in the hepatocyte nuclear factor-1 a gene in maturity-onset diabetes of the young (MODY3). Nature 384: 455-458
11. 11. Yamagata K, Furuta H, Oda N et al. (1996) Mutations in the hepatocyte nuclear factor-4a gene in maturity-onset diabetes of the young (MODY1). Nature 384: 458-460
12. 12. Andersen PH, Lund S, Vestergaard H, Junker S, Kahn BB, Pedersen O (1993) Expression of the major insulin regulatable glucose transporter (Glut 4) in skeletal muscle of non insulin-dependent diabetic patients and healthy subjects before and after insulin infusion. J Clin Endocrinol Metab 77: 27-32
13. 13. Schalin-Jänti C, Yki-Järvinen H, Koranyi L et al. (1994) Effect of insulin on Glut 4 mRNA and protein concentrations in skeletal muscle of patients with NIDDM and their first-degree relatives. Diabetologia 37: 401-407
14. 14. Pendergrass M, Koval J, Vogt C et al. (1998) Insulin-induced hexokinase II expression is reduced in obesity and NIDDM. Diabetes 47: 387-394
15. 15. Andreelli F, Laville M, Ducluzeau PH et al. (1999) Defective regulation of phosphatidylinositol-3-kinase gene expression in skeletal muscle and adipose tissue of non-insulin-dependent dibetes mellitus patients. Diabetologia 42: 358-364
16. 16. Millet L, Vidal H, Andreelli F et al. (1997) Increased uncoupling protein-2 and -3 mRNA expression during fasting in obese and lean humans. J Clin Invest 100: 2665-2670
17. 17. Wing RR (1995) Use of very-low-calorie diets in the treatment of obese persons with non-insulin-dependent diabetes mellitus. J Am Diet Assoc 95: 569-572
18. 18. Laville M, Rigalleau V, Riou JP, Beylot M (1995) Respective role of plasma non esterified fatty acids oxidation and total lipid oxidation in lipid-induced insulin resistance. Metabolism 44: 639-644
19. 19. Laville M, Auboeuf D, Khalfallah Y, Vega N, Riou JP, Vidal H (1996) Acute regulation by insulin of phosphatidylinositol-3-kinase, Rad, Glut4 and lipoprotein lipase mRNA levels in human muscle. J Clin Invest 98: 43-49
20. 20. Frayn KN (1983) Calculation of substrate oxidation rates in vivo from gaseous exchange. J Appl Physiol 55: 628-634
21. 21. Fery F, Baiasse EO (1994) Glucose metabolism during the starved-to-fed transition in obese patients with NIDDM. Diabetes 43: 1418-1425
22. 22. Chomczynski P, Sacchi N (1987) Single step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162: 156-159
23. 23. Wang AM, Doyle MV, Mark DF (1989) Quantitation of mRNA by the polymerase chain reaction. Proc Natl Acad Sci USA 86: 9717-9721
24. 24. Auboeuf D, Vidal H (1997) The use of the reverse transcription-competitive polymerase chain reaction to investigate the in vivo regulation of gene expression in small tissue samples. Anal Biochem 245: 141-148
25. 25. Mc Pherson M, Quirke P, Taylor G (1991) PCR, a practical approach. Oxford University Press, New York
26. 26. Pollare T, Vessby B, Lithell H (1991) Lipoprotein lipase activity in skeletal muscle is related to insulin sensitivity. Arteriosclerosis 11: 1192-1203
27. 27. Caro JF, Sinha MK, Raju SM et al. (1986) Insulin receptor kinase in human skeletal muscle from obsese subjects with and without noninsulin-dependent diabetes. J Clin Invest 79: 1330-1337
28. 28. Frederici M, Zucaro L, Porzio O et al. (1996) Increased expression of insulin/insulin-like growth factor-I hybrid receptors in skeletal muscle of noninsulin-dependent diabetes mellitus subjects. J Clin Invest 98: 2887-2893
29. 29. Okabayashi Y, Maddux BA, McDoanld AR, Logson CD, Williams JA, Goldfine ID (1989) Mechanism of insulin-induced insulin receptor downregulation. Decrease of receptor biosynthesis and mRNA levels. Diabetes 38: 182-187
30. 30. Mosthaf L, Vogt B, Häring HU, Ullrich A (1991) Altered expression of insulin receptor types A and B in the skeletal muscle of non-insulin-dependent diabetes mellitus patients. J Clin Invest 88: 4728-4730
31. 31. Benecke H, Flier JS, Moller DE (1992) Alternative spliced variants of the insulin receptor protein: Expression in normal and diabetic human tissues. J Clin Invest 89: 2066-2070
32. 32. Anderson CM, Henry RR, Knudson PE, Olefsky JM, Webster NJG (1993) Relative expression of insulin receptor isoforms does not differ in lean, obese and noninsulin-dependent diabetes mellitus subjects. J Clin Endocrinol Metab 76: 1380-1382
33. 33. Wiersam MML, Auboeuf D, Nieuwenhuizen-Bakker IM, Radder JK, Riou JP, Vidal H (1997) Insulin receptor mRNA splicing and altered metabolic control in aged and mildly insulin-deficient rats. Am J Physiol 272: E607-E615
34. 34. Garvey WT, Maianu L, Kennedy A et al. (1997) Muscle Rad expression and human metabolism: potential role of the novel Ras-related GTPase in energy expenditure and body composition. Diabetes 46: 444-450
35. 35. Kahn BB (1992) Facilitative glucose transporters: Regulatory mechanisms and dysregulation in diabetes. J Clin Invest 89: 1367-1374
36. 36. Kelley DE, Wing R, Buonocore C, Sturis J, Polonsky K, Fitzsimmons M (1993) Relative effects of calorie restriction and weight loss in noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab 77: 1287-1293
37. 37. Björnholm M, Kawano Y, Lehtihet M, Zierath JR (1997) Insulin receptor substrate-1 phosphorylation and phosphatidylinositol 3-kinase activity in skeletal muscle from NIDDM subjects after in vivo insulin stimulation. Diabetes 46: 524-527
38. 38. Baier LJ, Wiedrich C, Hanson RL, Bogardus C (1998) Variant in the regulatory subunit of phosphatidylinositol 3-kinase (p85α): preliminay evidence indicates a potential role of this variant in the acute insulin response and type 2 diabetes in Pima women. Diabetes 47: 973-975